163 related articles for article (PubMed ID: 30018559)
1. Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.
Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chen CC; Kao CH
Front Pharmacol; 2018; 9():718. PubMed ID: 30018559
[No Abstract] [Full Text] [Related]
2. Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case-control study.
Xiong J; Wang Y; Xu W; Liu Z; Wang H; Zhang Z; Han Y; Yin C; Cao S; Yang Z; Su T; Wei J; Chen G; Jin L
Liver Int; 2020 Nov; 40(11):2848-2857. PubMed ID: 32910500
[TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case-Control Study.
Peng YC; Lin CL; Hsu WY; Lu IT; Yeh HZ; Chang CS; Kao CH
Dose Response; 2018; 16(4):1559325818803283. PubMed ID: 30288155
[TBL] [Abstract][Full Text] [Related]
4. Association Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.
Peng YC; Lin CL; Yeh HZ; Chang CS; Wu YL; Kao CH
Medicine (Baltimore); 2016 Apr; 95(15):e3363. PubMed ID: 27082596
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study.
Wang YP; Liu CJ; Chen TJ; Lin YT; Fung CP
Aliment Pharmacol Ther; 2015 Jun; 41(11):1175-81. PubMed ID: 25871643
[TBL] [Abstract][Full Text] [Related]
6. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
7. Dose-Dependent Proton Pump Inhibitor Exposure and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study.
Kuo HY; Liang CS; Tsai SJ; Chen TJ; Chu CS; Chen MH
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886592
[TBL] [Abstract][Full Text] [Related]
8. Association between use of proton pump inhibitors and occurrence of colon diverticulitis.
Ho BL; Hu HY; Chang SS
J Chin Med Assoc; 2016 Jan; 79(1):5-10. PubMed ID: 26404898
[TBL] [Abstract][Full Text] [Related]
9. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
10. Statins are associated with a reduced risk of cholangiocarcinoma: a population-based case-control study.
Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Tung CF; Wu YL; Sung FC; Kao CH
Br J Clin Pharmacol; 2015 Oct; 80(4):755-61. PubMed ID: 25808421
[TBL] [Abstract][Full Text] [Related]
11. Association between Proton Pump Inhibitor Use and Parkinson's Disease in a Korean Population.
Kim JH; Oh JK; Kim YH; Kwon MJ; Kim JH; Choi HG
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337125
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and the risk of colorectal cancer.
van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
[TBL] [Abstract][Full Text] [Related]
13. Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19.
Wu S; Jin Z; Peng C; Li D; Cheng Y; Zhu R; He J; Wu C
J Glob Health; 2022; 12():05005. PubMed ID: 35198150
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: An Icelandic population-based case-control study.
Hálfdánarson ÓÖ; Fall K; Ogmundsdottir MH; Lund SH; Steingrímsson E; Ogmundsdottir HM; Zoega H
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):471-478. PubMed ID: 30565786
[TBL] [Abstract][Full Text] [Related]
15. Is use of a long-term proton pump inhibitor or histamine-2 receptor antagonist a risk factor for iron-deficiency anaemia in Taiwan? A neglected clinical drug-drug interaction.
Wu YT; Lu YT; Chu CY; Chao HJ; Kuo LN; Cheng KJ; Chen HY
Fam Pract; 2023 Sep; ():. PubMed ID: 37756627
[TBL] [Abstract][Full Text] [Related]
16. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study.
Bakhriansyah M; Souverein PC; de Boer A; Klungel OH
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1141-1148. PubMed ID: 28370857
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study.
Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y
Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896
[TBL] [Abstract][Full Text] [Related]
19. Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study.
Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chang CS; Kao CH
Medicine (Baltimore); 2015 Jun; 94(23):e926. PubMed ID: 26061315
[TBL] [Abstract][Full Text] [Related]
20. Use of Proton Pump Inhibitors and the Risk of Listeriosis: A Nationwide Registry-based Case-Control Study.
Kvistholm Jensen A; Simonsen J; Ethelberg S
Clin Infect Dis; 2017 Apr; 64(7):845-851. PubMed ID: 28013257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
